XML 56 R46.htm IDEA: XBRL DOCUMENT v3.25.0.1
Basis of Presentation and Significant Accounting Policies - Summary of Percentage of the Company's Total Net Product Revenue (Detail) - Revenue Benchmark [Member] - Customer Concentration Risk [Member]
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Customer A [Member]      
Concentration Risk [Line Items]      
Concentration risk, percentage 72.00% 65.20% 100.00%
Customer B [Member]      
Concentration Risk [Line Items]      
Concentration risk, percentage [1] 0.00% 34.80% 0.00%
Customers [Member]      
Concentration Risk [Line Items]      
Concentration risk, percentage 72.00% 100.00% 100.00%
[1] During 2023, the Company sold FYCOMPA® through a Transition Service Agreement with a U.S. subsidiary of Eisai. Effective January 1, 2024, FYCOMPA® is being sold and distributed through a third party logistics (3PL) organization under the Company's contracts.